foxo4 dri peptide senolytic 2023 FOXO4-DRI Dosing Guide: Peptide Protocol (June 2026) FOXO4-DRI | | 2460055-10-9 |
Description
As of April 2026, it remains on the Category 2 restricted compounding list pending the July advisory panel review
as such, it has a wide range of functions
Inflammation Modulation: Chronic inflammation is a common culprit behind many health issues, including pain and impaired healing
And 63% achieved at least 20% weight loss
[DOI] [PubMed] [Google Scholar] 73.Steiner J.M
Multi-strain blend, 80100 billion CFU per daily dose
